This study indicated that cathepsin B may be able to regulate the release of MMP-9 and VEGF, suggesting that the inhibition of cathepsin B will also inhibit tumor growth by inhibiting cathepsin B. Angiogenesis has emerged as a therapeutic approach to inhibiting glioma (128). Here, MMP9 is linked to central nervous system cancer.